PLX - Protalix BioTherapeutics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 558.76M
Enterprise Value 373.66M
Trailing P/E N/A
Forward P/E 11.13
PEG Ratio (5 yr expected) 1-0.26
Price/Sales (ttm)1.72
Price/Book (mrq)N/A
Enterprise Value/Revenue 32.15
Enterprise Value/EBITDA 6-4.18

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin -77.27%
Operating Margin (ttm)-56.39%

Management Effectiveness

Return on Assets (ttm)-18.10%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)34.24M
Revenue Per Share (ttm)0.23
Quarterly Revenue Growth (yoy)140.50%
Gross Profit (ttm)24.94M
EBITDA -17.64M
Net Income Avi to Common (ttm)-26.46M
Diluted EPS (ttm)-0.1800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.81M
Total Cash Per Share (mrq)0.25
Total Debt (mrq)52.27M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.09
Book Value Per Share (mrq)-0.36

Cash Flow Statement

Operating Cash Flow (ttm)-7.74M
Levered Free Cash Flow (ttm)-3.23M

Trading Information

Stock Price History

Beta (3Y Monthly) 4.10
52-Week Change 3-9.32%
S&P500 52-Week Change 34.96%
52 Week High 30.8300
52 Week Low 30.2700
50-Day Moving Average 30.4234
200-Day Moving Average 30.4302

Share Statistics

Avg Vol (3 month) 3315.27k
Avg Vol (10 day) 3147.8k
Shares Outstanding 5148.38M
Float 144.79M
% Held by Insiders 16.23%
% Held by Institutions 19.70%
Shares Short (Apr 30, 2019) 42.75M
Short Ratio (Apr 30, 2019) 413.65
Short % of Float (Apr 30, 2019) 41.90%
Short % of Shares Outstanding (Apr 30, 2019) 41.85%
Shares Short (prior month Mar 29, 2019) 42.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jan 3, 2007